$4.75
+0.10 (+2.12%)
Open$4.70
Previous Close$4.65
Day High$5.37
Day Low$4.41
52W High$15.22
52W Low$8.80
Volume—
Avg Volume493.7K
Market Cap196.48M
P/E Ratio57.20
EPS$0.22
SectorBiotechnology
Analyst Ratings
Buy
10 analysts
Price Target
+191.2% upside
Current
$4.75
$4.75
Target
$13.83
$13.83
$9.36
$13.83 avg
$17.78
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 116.64M | 118.58M | 115.83M |
| Net Income | -21,434,773 | -22,545,743 | -15,491,219 |
| Profit Margin | -18.4% | -19.0% | -13.4% |
| EBITDA | -23,823,087 | -23,688,809 | -21,137,696 |
| Free Cash Flow | -12,084,786 | -12,382,292 | -11,826,701 |
| Rev Growth | -8.2% | -9.4% | -4.9% |
| Debt/Equity | 0.42 | 0.48 | 0.50 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |